In focus
Latest feed
Teva Secures Landmark $400 Million Investment from Blackstone for Pivotal Respiratory Drug
The Eli Lilly Phenomenon: Unpacking the Rocket Fuel Behind the Stock's Astounding Climb
The Biotech Buzz: Is Abivax Poised to Be the Next Big Acquisition?
Navigating the Pharma Horizon: Nuvama's Top 7 Bets for a Robust Portfolio
